Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.

Therapeutic drug monitoring - 1 Feb 2000

Dahl M L, Sjöqvist F

Abstract excerpt

A short review of the metabolism of psychoactive drugs and the pharmacogenetic factors regulating the enzymes involved is presented here. The potential clinical usefulness of phenotyping and genotyping individuals, with regard to their drug metabolic capacity, is discussed. Indications for genotyping CYP2D6 and a flow scheme for the combined use of conventional therapeutic drug monitoring (TDM) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Antipsychotic Agents
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Monitoring

Share to Genotype

Share to Pharmacogenetics

Share to Phenotype

Source

Identifiers

PMID: 10688272
DOI: 10.1097/00007691-200002000-00024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.PMID 10688272Read ↗

Phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatry.Semantic proximity Read ↗

Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies.Semantic proximity Read ↗

The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.Semantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.Semantic proximity Read ↗

Cytochrome P450 2D6 genotyping: potential role in improving treatment outcomes in psychiatric disorders.Semantic proximity Read ↗

[Importance of genetic polymorphism of cytochrome P450 isoenzymes for the choice and regimes of antidepressant and antipsychotic dosing on an individual basis].Semantic proximity Read ↗

Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping.Semantic proximity Read ↗

Pharmacogenetics: From Bench to ByteSemantic proximity Read ↗

[The value of pharmacogenetic tests in antidepressive medication therapy].Semantic proximity Read ↗

Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.Semantic proximity Read ↗

Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency.Semantic proximity Read ↗

Pharmacogenetics-guided dose modifications of antidepressants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.